Vertical with Vidir: Technology and Automation Lead Changes in Retail Industry Post-COVID

 

With the COVID-19 Pandemic, many companies moved online. Vidir and the broader world are seeing a lot of changes in the retail industry. The demand for automation and new technology is forcing retail outlets to change how they do business.

Mario Fontes, Director of Sales and Marketing for Vidir Solutions, “a leading manufacturer and worldwide supplier of vertical motorized storage carousels and display systems,” has seen many industry changes. First, he saw the barcode’s introduction and how retailers had to adjust or be left behind. Now, he sees another shift.

“We’ve seen some dramatic shifts, almost seismic,” Fontes said. He elaborated there were many changes before COVID, but it exacerbated and accelerated the need for change.

Those in the retail industry need to adjust to the changes to omnichannel sales and marketing departments. On the backend, in warehouses, they had to adjust how to support fulfillment and inventory management. Enter automation and technology

Kel Guerin, Co-Founder and Chief Innovation Officer for READY Robotics, has also noticed the need for automation and technology. READY Robotics ”builds software that fundamentally makes it easier to deploy robotic automation. A lot of that automation is in the manufacturing space.” They are soon launching automation in the retail space.

“This is a trend that has been going on for a while, the need to adopt automation,” Guerin said. He noticed that the pandemic pushed the need for automation to the front-end of the retail business. It solves the problem of the need for high dependency on human labor. Currently, they are trying to install these systems as fast as possible to meet the demand.

But, that doesn’t mean there isn’t a need for human labor as automation increases.

“The industry has realized the value of the individual in the store is not in stocking shelves or moving products through the store,” Fontes said. “The value is in what they do to serve the customer.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More